Today's episode promises insightful discourse as we welcome Professor Gerrit Borchard. Gerrit Borchard is a licensed pharmacist and obtained his Ph.D. in pharmaceutical technology from the University of Frankfurt (Germany). After holding several academic positions at Saarland (Germany) and at Leiden University (The Netherlands), he joined Enzon Pharmaceuticals, Inc. (USA) as Vice President Research. In 2005, he was appointed Full Professor of Biopharmaceutics at the University of Geneva (Switzerland), and in 2015, he was an invited professor at Graz University (Austria). He was president of the Swiss Academy of Pharmaceutical Sciences (SAPhS) from 2014 to 2022 and serves as president of the School of Pharmaceutical Sciences at the University of Geneva since 2022.

Prof. Borchard's research interests lie in the fields of biopharmaceutical sciences, nanomedicine and vaccine development. He has published more than 150 scientific papers (13052 citations, h-factor 57) and 23 book chapters, he edited two books, is named as inventor on 10 patents, and gave over 230 invited lectures.

In 2012 he joined the Non-Biological Complex Drugs (NBCD) working group hosted at Lygature (Utrecht, The Netherlands), joining its steering committee in 2015. He joined the External Advisory board of the EU-Nanotechnology Characterization Laboratory (EU-NCL) in 2016 and was Chair of the NBC working party at the European Directorate for the Quality of Medicines & Health Care (EDQM) from 2016 to 2023. In November 2022 he was appointed Chair of the mRNA Vaccine working party at EDQM.

Having been exposed to a variety of different work environments, he became fluent in the Dutch, English, French and German languages. Being an enthusiastic long-distance runner, he loves to roam the trails and by-roads of the Swiss mountains.

Check the episode here.